cardiovascular disease

(redirected from Cardiovascular diseases)
Also found in: Dictionary, Medical, Encyclopedia, Wikipedia.
  • noun

Words related to cardiovascular disease

References in periodicals archive ?
Maternal undernutrition can lead to intrauterine growth retardation and has been shown to increase the risk of metabolic disorders such as diabetes, hypertension, and cardiovascular disease in the offspring.
It is a terrible indictment of the entire medical establishment that we experience such high rates of cardiovascular diseases, suffer such misery, and spend so much money on a medical approach to a largely avoidable disease.
Possible benefits include reduced risk of cardiovascular disease and cancer, maintenance of healthy skin.
Cardiovascular disease ranks as the leading cause of death in this country.
Cardiovascular disease (CVD) is the leading cause of death among Americans.
Read the full report: Cardiovascular Diseases Therapeutics in Major Developed Markets to 2019 - Increasing Prevalence and Promising Novel Drugs offset Patent Cliff Threat utm_campaign=Pathology
Therefore, in the present study we investigated the mechanism of arsenic-induced vascular dysfunction and its possible contribution to cardiovascular diseases.
The current study demonstrates that EP-3533 can distinguish viable from non-viable myocardium, a potential large market opportunity in cardiovascular disease imaging.
However, the diversity of cardiovascular diseases arising from chronic arsenic exposure also raises the possibility that arsenic may alter the normal functioning of blood vessels, which are involved in various cardiovascular disorders.
Amorcyte), a privately funded biotechnology company developing cell therapy products to treat cardiovascular disease, announced today that its phase I clinical trial is now open in two new clinical sites and the data safety monitoring board has approved the trial going forward to the second stage using, as per the approved protocol, an increased number of stem cells.
As demonstrated with the discovery and development of ivabradine, the first selective and specific inhibitor of the sinus node I(f) current, Servier is committed to offer novel treatments to patients with cardiovascular diseases.
As the report states, cardiovascular diseases are the leading causes of death in women in the United States, claiming more lives than cancer, accidents and diabetes combined.
The general principle is that once blood perfusion is increased in the affected areas, patients with cardiovascular diseases may experience an improvement in tissue repair and function.
When blood perfusion is established in affected areas, patients with cardiovascular diseases may experience an increase in life expectancy and quality of life.
Full browser ?